Inovio said, depending on the results of its mid-stage trial, it would run the late-stage study for its vaccine candidate, INO-4800, with partners such as China’s Advaccine and the International Vaccine Institute.
Cellid and the International Vaccine Institute (IVI) have signed a research service contract to collaborate in the clinical development of the Covid-19 vaccine, AdCLD-CoV19.
First cooperative program between International Vaccine Institute and Translational Health Science and Technology Institute expected to help accelerate cooperation between India and IVI